Impel NeuroPharma

+$0.20 (+2.10%) As of 3:18 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMPL and other ETFs, options, and stocks.

About IMPL

Impel NeuroPharma, Inc. operates as clinical stage biotechnology firm that develops medical devices. It offers intranasal drug treatments for central nervous system (CNS) disorders.

CEO
Adrian Adams
Employees
63
Headquarters
Seattle, Washington
Founded
2008

IMPL Key Statistics

Market Cap
218.57M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
495.73K
High Today
$9.86
Low Today
$9.51
Open Price
$9.62
Volume
63.54K
52 Week High
$34.75
52 Week Low
$6.90

IMPL Earnings

-$0.79
-$0.53
-$0.26
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure